109 related articles for article (PubMed ID: 9265313)
1. [Sedimentation rate and renal cancer].
Iversen OH; Røger M; Wetteland P; Solberg HE
Tidsskr Nor Laegeforen; 1997 Jun; 117(17):2493-6. PubMed ID: 9265313
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma.
Hannisdal E; Bostad L; Grøttum KA; Langmark F
Eur J Surg Oncol; 1989 Aug; 15(4):333-6. PubMed ID: 2759251
[TBL] [Abstract][Full Text] [Related]
3. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in renal cell carcinoma].
Uchida T; Shinohara K; Kobayashi K; Honda N; Ao T; Omata T; Odajima K; Koshiba K
Hinyokika Kiyo; 1986 Jul; 32(7):929-40. PubMed ID: 3776772
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological observation on renal cell carcinoma. "The relationship between the histological and clinical findings"].
Yoneda F; Tsujimura H; Kagawa S; Kurokawa K; Akagi G
Hinyokika Kiyo; 1985 Sep; 31(9):1525-9. PubMed ID: 2417462
[TBL] [Abstract][Full Text] [Related]
7. Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.
Kawai Y; Matsuyama H; Korenaga Y; Misumi T; Eguchi S; Hara T; Nagao K; Ohmi C; Sakano S; Naito K
Urol Int; 2009; 83(3):306-10. PubMed ID: 19829031
[TBL] [Abstract][Full Text] [Related]
8. Rising erythrocyte sedimentation rate during several years before diagnosis can be a predictive factor in 70% of renal cell carcinoma patients. The benefit of knowing subject-based reference values.
Iversen OH; Røger M; Solberg HE; Wetteland P
J Intern Med; 1996 Sep; 240(3):133-41. PubMed ID: 8862122
[TBL] [Abstract][Full Text] [Related]
9. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma.
Hoffmann R; Franzke A; Buer J; Sel S; Oevermann K; Duensing A; Probst M; Duensing S; Kirchner H; Ganser A; Atzpodien J
Br J Cancer; 1999 Apr; 79(11-12):1742-5. PubMed ID: 10206286
[TBL] [Abstract][Full Text] [Related]
11. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
12. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
[TBL] [Abstract][Full Text] [Related]
13. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
14. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.
Alamdari FI; Rasmuson T; Grankvist K; Ljungberg B
Scand J Urol Nephrol; 2007; 41(1):5-9. PubMed ID: 17366095
[TBL] [Abstract][Full Text] [Related]
18. Sigma ESR: an erythrocyte sedimentation rate adjusted for the hematocrit and hemoglobin concentration.
Pawlotsky Y; Goasguen J; Guggenbuhl P; Veillard E; Jard C; Pouchard M; Perdriger A; Meadeb J; Chalès G
Am J Clin Pathol; 2004 Nov; 122(5):802-10. PubMed ID: 15491977
[TBL] [Abstract][Full Text] [Related]
19. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte sedimentation rates in patients with renal cell carcinoma.
Dönmez T; Kale M; Ozyürek Y; Atalay H
Eur Urol; 1992; 21 Suppl 1():51-2. PubMed ID: 1425838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
